Company profile for Kane Biotech

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

We are a Canadian-based technology company engaged in the development and commercialization of products that prevent and remove microbial biofilms.Kane Biotech is a discovery and development company focused on novel products that prevent and disperse bacterial biofilms. Kane was formed to translate these discoveries into innovative solutions for human and animal health, as well as industrial applications. Kane’s commercial s...
We are a Canadian-based technology company engaged in the development and commercialization of products that prevent and remove microbial biofilms.Kane Biotech is a discovery and development company focused on novel products that prevent and disperse bacterial biofilms. Kane was formed to translate these discoveries into innovative solutions for human and animal health, as well as industrial applications. Kane’s commercial strategy is to create value for shareholders through the establishment of global partnerships and licensing agreements with leading companies to commercialize our innovations.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
Canada
Address
Address
290-100 Innovation Drive Winnipeg, Manitoba, Canada R3T 6G2
Telephone
Telephone
204.453.1301
youtube
YouTube

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Default Event

DDL Conference

Not Confirmed

envelop Contact Supplier

DDL Conference

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.globenewswire.com/news-release/2025/11/28/3196215/0/en/Kane-Biotech-Announces-Third-Quarter-2025-Financial-Results.html

GLOBENEWSWIRE
28 Nov 2025

https://www.globenewswire.com/news-release/2025/11/27/3195633/0/en/Kane-Biotech-Announces-New-Private-Placement-Offering.html

GLOBENEWSWIRE
27 Nov 2025

https://www.globenewswire.com/news-release/2025/11/04/3180192/0/en/Kane-Biotech-Presents-revyve-Data-at-Diabetic-Foot-and-Southern-Region-Burn-Conferences.html

GLOBENEWSWIRE
04 Nov 2025

https://www.globenewswire.com/news-release/2025/09/16/3151250/0/en/Kane-Biotech-Completes-U-S-FDA-510-k-Submission-for-revyve-Antimicrobial-Wound-Cleanser.html

GLOBENEWSWIRE
16 Sep 2025

https://www.globenewswire.com/news-release/2025/09/10/3148267/0/en/Kane-Biotech-Completes-Enrollment-in-U-S-Case-Series-Studies-of-its-revyve-Antimicrobial-Wound-Gel-and-Spray.html

GLOBENEWSWIRE
10 Sep 2025

https://www.globenewswire.com/news-release/2025/09/04/3144446/0/en/Kane-Biotech-to-Present-revyve-Clinical-Data-at-Symposium-on-Advanced-Wound-Care-SAWC-Fall-Conference.html

GLOBENEWSWIRE
04 Sep 2025

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty